These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32100258)

  • 41. Detection of Hepatitis B Virus-Host Junction Sequences in Urine of Infected Patients.
    Lin SY; Su YP; Trauger ER; Song BP; Thompson EGC; Hoffman MC; Chang TT; Lin YJ; Kao YL; Cui Y; Hann HW; Park G; Shieh FS; Song W; Su YH
    Hepatol Commun; 2021 Oct; 5(10):1649-1659. PubMed ID: 34558837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma.
    Wong DK; Yuen MF; Poon RT; Yuen JC; Fung J; Lai CL
    J Hepatol; 2006 Oct; 45(4):553-9. PubMed ID: 16904225
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of HBV Genomes Integrated into the Genomes of Human Hepatoma PLC/PRF/5 Cells by HBV Sequence Capture-Based Next-Generation Sequencing.
    Ishii T; Tamura A; Shibata T; Kuroda K; Kanda T; Sugiyama M; Mizokami M; Moriyama M
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32570699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complete genome sequencing and clinical analysis of intrahepatic hepatitis B virus cccDNA from HCC.
    Jiao F; Long L; Ding S; Xie X; Jia L; Lu F
    Microb Pathog; 2017 Aug; 109():49-55. PubMed ID: 28478205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment.
    Gil-García AI; Madejón A; Francisco-Recuero I; López-López A; Villafranca E; Romero M; García A; Olveira A; Mena R; Larrubia JR; García-Samaniego J
    World J Gastroenterol; 2019 Oct; 25(38):5883-5896. PubMed ID: 31636479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis B virus DNA integration in hepatocellular carcinomas and their adjacent non-neoplastic liver tissues.
    Ding JJ; Saito H; Morizane T; Kagawa T; Matsumoto S; Iwabuchi N; Tsuchiya M; Watanabe T; Kumagai N; Tsuchimoto K
    Keio J Med; 1989 Dec; 38(4):443-53. PubMed ID: 2560999
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen.
    Murakami Y; Minami M; Daimon Y; Okanoue T
    J Med Virol; 2004 Feb; 72(2):203-14. PubMed ID: 14695661
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
    J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum hepatitis B surface antigen is correlated with intrahepatic total HBV DNA and cccDNA in treatment-naïve patients with chronic hepatitis B but not in patients with HBV related hepatocellular carcinoma.
    Wang M; Qiu N; Lu S; Xiu D; Yu J; Wang XT; Lu F; Li T; Liu X; Zhuang H
    J Med Virol; 2013 Feb; 85(2):219-27. PubMed ID: 23168998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HBV genome integration and genetic instability in HBsAg-negative and anti-HCV-positive hepatocellular carcinoma in Japan.
    Matsuzaki Y; Chiba T; Hadama T; Asaoka H; Doy M; Shoda J; Tanaka N; Kinoshita M
    Cancer Lett; 1997 Oct; 119(1):53-61. PubMed ID: 18372522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spatial transcriptomics reveals a low extent of transcriptionally active hepatitis B virus integration in patients with HBsAg loss.
    Yu X; Gong Q; Yu D; Chen Y; Jing Y; Zoulim F; Zhang X
    Gut; 2024 Apr; 73(5):797-809. PubMed ID: 37968095
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.
    Toyoda H; Kumada T; Kaneoka Y; Murakami Y
    J Hepatol; 2008 Jan; 48(1):43-50. PubMed ID: 18023912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integration of hepatitis B virus DNA into the myeloid/lymphoid or mixed-lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma.
    Saigo K; Yoshida K; Ikeda R; Sakamoto Y; Murakami Y; Urashima T; Asano T; Kenmochi T; Inoue I
    Hum Mutat; 2008 May; 29(5):703-8. PubMed ID: 18320596
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distinct Patterns of HBV Integration and
    Jang JW; Kim HS; Kim JS; Lee SK; Han JW; Sung PS; Bae SH; Choi JY; Yoon SK; Han DJ; Kim TM; Roberts LR
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209079
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
    Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
    Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis B Virus Pregenomic RNA in Hepatocellular Carcinoma: A Nosological and Prognostic Determinant.
    Halgand B; Desterke C; Rivière L; Fallot G; Sebagh M; Calderaro J; Bioulac-Sage P; Neuveut C; Buendia MA; Samuel D; Féray C
    Hepatology; 2018 Jan; 67(1):86-96. PubMed ID: 28802063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection.
    Pollicino T; Squadrito G; Cerenzia G; Cacciola I; Raffa G; Craxi A; Farinati F; Missale G; Smedile A; Tiribelli C; Villa E; Raimondo G
    Gastroenterology; 2004 Jan; 126(1):102-10. PubMed ID: 14699492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.